MAPT and Alzheimer disease: A main strength of our study is the inclusion of neuropathologically proven cases of AD and FTLD, including both FTLD-tau and FTLD-TDP, which allowed us to study relationships between neuroanatomical locations of WMH and neuropsychiatric manifestations in pathologically confirmed neurodegenerative disease groups.